Zi‐Liang Wu

456 citations
13 papers · 406 indexed · h-index 4

Zi‐Liang Wu

13 papers receiving 394 citations

Peers

Zi‐Liang Wu
Comparison fields: 5 of 40
  • Neurology 233
  • Immunology 115
  • Cancer Research 72
  • Molecular Biology 253
  • Oncology 85
Replace Kaat Durinck with:
Kaat Durinck Belgium
Peter Stroeken Netherlands
L. Drivsholm Denmark
Huan-Hsien Kuo Taiwan
Arianna Citti Italy
M C Gendron France
Kim L. Nguyen United States
Robyn T. Sussman United States
Christopher F. Bassil United States
Alan Hall United Kingdom
Zi‐Liang Wu relative to Kaat Durinck Belgium Kaat Durinck's profile →
Citations per field
00.5×3.1×
Kaat Durinck · 1×
Citations per year

Countries citing papers authored by Zi‐Liang Wu

Since Specialization
Citations

This map shows the geographic impact of Zi‐Liang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Liang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Liang Wu more than expected).

Fields of papers citing papers by Zi‐Liang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi‐Liang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Liang Wu. The network helps show where Zi‐Liang Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zi‐Liang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zi‐Liang Wu Line = papers co-authored together Zi‐Liang Wu links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20171
2
[Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
20111
3
[Detecting phospho-signaling protein of bone marrow leukemia cells by phospho-signaling flow cytometry].
20111
4
[Biological characteristics of bone marrow-derived mesenchymal stem cells in children with acute leukemia].
20091
5
[Preliminary study on the safety and pharmacodynamic action of low dose L-asparaginase].
20061
6
[Detection of mdr1 gene by real-time fluorescence quantitative polymerase chain reaction using Taq Man-MGB probe].
20061
7
[Study on the expression of human ERMAP gene in erythropoietic and macrophage differentiation of K562 cells].
20051
8
[Research on the pharmacokinetics and pharmacodynamics of L-asparaginase during its treatment of childhood acute lymphoblastic leukemia].
20051
9
[Expression of human ERMAP gene in different cell lines].
20051
10 1987120
11
Expression of GD2 ganglioside by untreated primary human neuroblastomas.
1986173
12 19858
13 198596

About Zi‐Liang Wu

Zi‐Liang Wu is a scholar working on Cancer Research, Neurology, Genetics, Physiology and Biotechnology, having authored 13 papers that have together received 406 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Glycosylation and Glycoproteins Research (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Neuroblastoma Research and Treatments (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Mesenchymal stem cell research (2 papers), interferon and immune responses (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Neurology (233 citations), Immunology (115 citations), Cancer Research (72 citations), Molecular Biology (253 citations) and Oncology (85 citations). Zi‐Liang Wu has collaborated with scholars based in China and United States. Frequent co-authors include Stephan Ladisch, Robert C. Seeger, Stephen A. Feig, Frances M. Wiley, Carl Lenarsky, Stephan Ladisch, Wei‐Dong Yu, Yingyi He, Yong-Hong Lai and Tao Jia. Their work appears in journals such as International Journal of Cancer, American Journal of Hematology, The Lancet, PubMed Central and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026